EUVIMEDEUVIMED entdecken
Open Access

Decreased blood oxytocin levels in obesity and in patients with newly diagnosed type 2 diabetes

S Sh Anvarova, G D Narimova

Problems of Endocrinology · 20.05.2026 · 72 (2) · 61-68

DOI: 10.14341/probl13587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Problems of Endocrinology, online erschienen am 20.05.2026. Verfasst von S Sh Anvarova und 1 weiteren Autor:innen. Beteiligte Einrichtung: Republican Specialized Scientific and Practical Center of Endocrinology named after Acad. Y.H. Turakulov. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Oxytocin, Obesity. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND . Obesity and type 2 diabetes (T2D) are common metabolic disorders. Oxytocin, a hypothalamic neuropeptide, has recently been recognized as a potential regulator of energy balance, appetite, and insulin sensitivity. OBJECTIVE . To investigate the relationship between circulating oxytocin levels and metabolic parameters in individuals with obesity and newly diagnosed T2D. MATERIALS AND METHODS . A total of 96 participants were enrolled, including 48 with normal glucose tolerance (NGT) and 48 with newly diagnosed T2D, each subdivided into normal-weight and obese groups. Anthropometric indices, glucose and lipid parameters, insulin, HbA 1c , and high-sensitivity C-reactive protein were measured. Insulin resistance and β-cell function were assessed using the HOMA model. RESULTS . Circulating oxytocin levels were significantly lower in patients with T2D compared to NGT (p < 0.01), and in obese compared to normal-weight participants (p < 0.01). Low oxytocin was negatively correlated with BMI, waist circumference, HbA1c, glucose, insulin, lipids, and hs-CRP, but positively with β-cell function. Multiple regression analysis identified 2-hour glucose, BMI, and total cholesterol as independent predictors of oxytocin levels. CONCLUSION . Patients with obesity and newly diagnosed T2D exhibit markedly reduced circulating oxytocin levels, associated with adverse metabolic profiles. These findings highlight oxytocin as a potential biomarker of early metabolic dysregulation and suggest new therapeutic perspectives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2OxytocinObesityHumansFemaleMaleMiddle AgedInsulin ResistanceBlood GlucoseC-Reactive ProteinInsulinGlycated HemoglobinBody Mass IndexAdult

Substanzen

OxytocinBlood GlucoseC-Reactive ProteinInsulinGlycated Hemoglobin

Autor:innen und Institutionen

  • Republican Specialized Scientific and Practical Center of Endocrinology named after Acad. Y.H. Turakulov.

Zitieren

APA

Anvarova, S. S., & Narimova, G. D. (2026). Decreased blood oxytocin levels in obesity and in patients with newly diagnosed type 2 diabetes. Problems of Endocrinology, 72(2), 61-68. https://doi.org/10.14341/probl13587

Vancouver

Anvarova SS, Narimova GD. Decreased blood oxytocin levels in obesity and in patients with newly diagnosed type 2 diabetes. Problems of Endocrinology. 2026;72(2):61-68. doi:10.14341/probl13587

BibTeX
@article{Anvarova2026,
  author = {Anvarova, S Sh and Narimova, G D},
  title = {Decreased blood oxytocin levels in obesity and in patients with newly diagnosed type 2 diabetes},
  journal = {Problems of Endocrinology},
  year = {2026},
  volume = {72},
  number = {2},
  pages = {61--68},
  doi = {10.14341/probl13587}
}
Kostenlos starten →